3 results
Approved WMOCompleted
Our study tries to identify the ideal sclerosant dosage for the ClariVein® system in order to occlude the GSV permanently. By choosing the lowest dose with the same anatomical success rate, we achieve a safe treatment which also gives us the…
Approved WMOCompleted
The main objective of Study M15-722 is to characterize the efficacy, safety, and tolerability of ravagalimab (ABBV-323) as induction treatment in subjects with moderately to severely active UC.
Subjective assessment of amplitude-modulated music by hearing aid wearers and cochlear implant users
The main objective is to assess the perceived sound quality of different music excerpts that are modified using the modulation-depth algorithm (MDA) of Golden Hearing by CI users and hearing aid (HA) wearers. To this end a suitable graphical user…